1887
  1. Home
  2. Eurosurveillance
  3. Volume 26, Issue 3, 21/Jan/2021
  4. Article
Rapid communication Open Access
Like 0
Download

Abstract

We report the strategy leading to the first detection of variant of concern 202012/01 (VOC) in France (21 December 2020). First, the spike (S) deletion H69–V70 (ΔH69/ΔV70), identified in certain SARS-CoV-2 variants including VOC, is screened for. This deletion is associated with a S-gene target failure (SGTF) in the three-target RT-PCR assay (TaqPath kit). Subsequently, SGTF samples are whole genome sequenced. This approach revealed mutations co-occurring with ΔH69/ΔV70 including S:N501Y in the VOC.

© Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
Loading

Article metrics loading...

/content/10.2807/1560-7917.ES.2021.26.3.2100008
2021-01-21
2025-05-01
/content/10.2807/1560-7917.ES.2021.26.3.2100008
Loading
Loading full text...

Full text loading...

/deliver/fulltext/eurosurveillance/26/3/eurosurv-26-3-2.html?itemId=/content/10.2807/1560-7917.ES.2021.26.3.2100008&mimeType=html&fmt=ahah

References

  1. European Centre for Disease Prevention and Control (ECDC). ECDC to assess risk associated with spread of SARS-CoV-2 in mink farms. Stockholm: ECDC; 2020. [Accessed 8 Nov 2020]. Available from: https://www.ecdc.europa.eu/en/news-events/ecdc-assess-risk-associated-spread-sars-cov-2-mink-farms
  2. World Health Organization (WHO). SARS-CoV-2 mink-associated variant strain – Denmark. Geneva: WHO. [Accessed 25 Nov 2020]. Available from: http://www.who.int/csr/don/06-november-2020-mink-associated-sars-cov2-denmark/en/
  3. Lassaunière R, Fonager J, Rasmussen M, Frische A, Polacek Strandh C, Bruun Rasmussen T, et al. Working paper on SARS-CoV-2 spike mutations arising in Danish mink, their spread to humans and neutralization data. Copenhagen: Statens Serum Institut. Available from: https://files.ssi.dk/Mink-cluster-5-short-report_AFO2
  4. Kemp SA, Datir RP, Collier DA, Ferreira I, Carabelli A, Harvey W, et al. Recurrent emergence and transmission of a SARS-CoV-2 Spike deletion ΔH69/ΔV70. bioRxiv. 2020:2020.12.14.422555; (Preprint). https://doi.org/10.1101/2020.12.14.422555
  5. Thomson EC, Rosen LE, Shepherd JG, Spreafico R, Filipe A da S, Wojcechowskyj JA, et al. The circulating SARS-CoV-2 spike variant N439K maintains fitness while evading antibody-mediated immunity. bioRxiv. 2020:2020.11.04.355842.(Preprint). https://doi.org/10.1101/2020.11.04.355842
  6. Andrew Rambaut, Nick Loman, Oliver Pybus, Wendy Barclay, Jeff Barrett, Alesandro Carabelli, Tom Connor, Tom Peacock, David L Robertson, Erik Volz, on behalf of COVID-19 Genomics Consortium UK (CoG-UK). Preliminary genomic characterisation of an emergent SARS-CoV-2 lineage in the UK defined by a novel set of spike mutations. Virological.org. [Accessed 21 Dec 2020]. Available from: https://virological.org/t/preliminary-genomic-characterisation-of-an-emergent-sars-cov-2-lineage-in-the-uk-defined-by-a-novel-set-of-spike-mutations/563/1
  7. Bal A, Destras G, Gaymard A, Bouscambert-Duchamp M, Valette M, Escuret V, et al. Molecular characterization of SARS-CoV-2 in the first COVID-19 cluster in France reveals an amino acid deletion in nsp2 (Asp268del). Clin Microbiol Infect. 2020;26(7):960-2.  https://doi.org/10.1016/j.cmi.2020.03.020  PMID: 32234449 
  8. Singer J, Gifford R, Cotten M, Robertson D. CoV-GLUE: A Web Application for Tracking SARS-CoV-2 Genomic Variation. 2020. doi: https://doi.org/10.20944/preprints202006.0225.v1 .
  9. Charre C, Ginevra C, Sabatier M, Regue H, Destras G, Brun S, et al. Evaluation of NGS-based approaches for SARS-CoV-2 whole genome characterisation. Virus Evol. 2020;6(2):veaa075.  https://doi.org/10.1093/ve/veaa075  PMID: 33318859 
  10. World Health Organization (WHO). Molecular assays to diagnose COVID-19: Summary table of available protocols. Geneva: WHO; 24 January 2020. Available from: https://www.who.int/publications/m/item/molecular-assays-to-diagnose-covid-19-summary-table-of-available-protocols
  11. Weisblum Y, Schmidt F, Zhang F, DaSilva J, Poston D, Lorenzi JC, et al. Escape from neutralizing antibodies by SARS-CoV-2 spike protein variants. eLife. 2020;9:e61312.  https://doi.org/10.7554/eLife.61312  PMID: 33112236 
  12. Baum A, Fulton BO, Wloga E, Copin R, Pascal KE, Russo V, et al. Antibody cocktail to SARS-CoV-2 spike protein prevents rapid mutational escape seen with individual antibodies. Science. 2020;369(6506):1014-8.  https://doi.org/10.1126/science.abd0831  PMID: 32540904 
  13. Starr TN, Greaney AJ, Hilton SK, Ellis D, Crawford KHD, Dingens AS, et al. Deep Mutational Scanning of SARS-CoV-2 Receptor Binding Domain Reveals Constraints on Folding and ACE2 Binding. Cell. 2020;182(5):1295-1310.e20.  https://doi.org/10.1016/j.cell.2020.08.012  PMID: 32841599 
  14. Volz E, Mishra S, Chand M, Barrett JC, Johnson R, Geidelberg L, et al. Transmission of SARS-CoV-2 Lineage B.1.1.7 in England: Insights from linking epidemiological and genetic data. medRxiv. 2020: 2020.12.30.20249034. (Preprint). https://doi.org/ https://doi.org/10.1101/2020.12.30.20249034 
  15. Kemp SA, Collier DA, Datir R, Gayed S, Jahun A, Hosmillo M, et al. Neutralising antibodies drive Spike mediated SARS-CoV-2 adaptation. medRxiv. 2020:2020.12.05.20241927. (Preprint). https://doi.org/10.1101/2020.12.05.20241927
  16. Soh WT, Liu Y, Nakayama EE, Ono C, Torii S, Nakagami H, et al. The N-terminal domain of spike glycoprotein mediates SARS-CoV-2 infection by associating with L-SIGN and DC-SIGN. bioRxiv. 2020:2020.11.05.369264. (Preprint). doi: https://doi.org/10.1101/2020.11.05.369264
  17. Chi X, Yan R, Zhang J, Zhang G, Zhang Y, Hao M, et al. A neutralizing human antibody binds to the N-terminal domain of the Spike protein of SARS-CoV-2. Science. 2020;369(6504):650-5.  https://doi.org/10.1126/science.abc6952  PMID: 32571838 
  18. McCarthy KR, Rennick LJ, Nambulli S, Robinson-McCarthy LR, Bain WG, Haidar G, et al. Recurrent deletions in the SARS-CoV-2 spike glycoprotein drive antibody escape. bioRxiv. 2020:2020.11.19.389916. (Preprint). https://doi.org/10.1101/2020.11.19.389916
  19. Tegally H, Wilkinson E, Giovanetti M, Iranzadeh A, Fonseca V, Giandhari J et al. Emergence and rapid spread of a new severe acute respiratory syndrome-related coronavirus 2 (SARS-CoV-2) lineage with multiple spike mutations in South Africa. medRxiv. 2020:2020.12.21.20248640. (Preprint). https://doi.org/ https://doi.org/10.1101/2020.12.21.20248640 
  20. Public Health England (PHE). Investigation of novel SARS-COV-2 variant. Variant of Concern 202012/01. London: PHE. Available from: https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/947048/Technical_Briefing_VOC_SH_NJL2_SH2.pdf
Two-step strategy for the identification of SARS-CoV-2 variant of concern 202012/01 and other variants with spike deletion H69–V70, France, August to December 2020
<p class="citation"> <span>Citation style for this article:</span> <span class="meta-value authors"> <a href="/search?value1=Antonin+Bal&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Bal Antonin</a>, <a href="/search?value1=Gregory+Destras&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Destras Gregory</a>, <a href="/search?value1=Alexandre+Gaymard&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Gaymard Alexandre</a>, <a href="/search?value1=Karl+Stefic&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Stefic Karl</a>, <a href="/search?value1=Julien+Marlet&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Marlet Julien</a>, <a href="/search?value1=S%C3%A9bastien+Eymieux&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Eymieux Sébastien</a>, <a href="/search?value1=Hadrien+Regue&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Regue Hadrien</a>, <a href="/search?value1=Quentin+Semanas&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Semanas Quentin</a>, <a href="/search?value1=Constance+d%E2%80%99Aubarede&option1=author&noRedirect=true" class="nonDisambigAuthorLink">d’Aubarede Constance</a>, <a href="/search?value1=Genevi%C3%A8ve+Billaud&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Billaud Geneviève</a>, <a href="/search?value1=Fr%C3%A9d%C3%A9ric+Laurent&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Laurent Frédéric</a>, <a href="/search?value1=Claudia+Gonzalez&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Gonzalez Claudia</a>, <a href="/search?value1=Yahia+Mekki&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Mekki Yahia</a>, <a href="/search?value1=Martine+Valette&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Valette Martine</a>, <a href="/search?value1=Maude+Bouscambert&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Bouscambert Maude</a>, <a href="/search?value1=Catherine+Gaudy-Graffin&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Gaudy-Graffin Catherine</a>, <a href="/search?value1=Bruno+Lina&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Lina Bruno</a>, <a href="/search?value1=Florence+Morfin&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Morfin Florence</a>, <a href="/search?value1=Laurence+Josset&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Josset Laurence</a>, <a href="/search?value1=the+COVID-Diagnosis+HCL+Study+Group&option1=author&noRedirect=true" class="nonDisambigAuthorLink">the COVID-Diagnosis HCL Study Group</a></span>. Two-step strategy for the identification of SARS-CoV-2 variant of concern 202012/01 and other variants with spike deletion H69–V70, France, August to December 2020. <a href="/content/ecdc">Euro Surveill.</a> 2021;26(3):pii=2100008. <a href="https://doi.org/10.2807/1560-7917.ES.2021.26.3.2100008" title="doi link" target="_blank">https://doi.org/10.2807/1560-7917.ES.2021.26.3.2100008</a> <span class="ES_Article_citation"> <span class="generated">Received</span>: 05 Jan 2021;&nbsp;&nbsp; <span class="generated">Accepted</span>: 21 Jan 2021 </span> </p>
/content/10.2807/1560-7917.ES.2021.26.3.2100008
/content/10.2807/1560-7917.ES.2021.26.3.2100008
Loading

Data & Media loading...

Submit comment
Close
Comment moderation successfully completed
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error